Although they are widely touted on TV, on the Internet, and in newspaper and magazine ads, colon cleansing regimens have

• No proof  that they are effective in promoting general health or well-being.
• Lots of evidence that they are actually harmful, even potentially life-threatening.

Administered either orally as teas, pills, or powders or through the rectum as high-powered enemas or colonic hydrotherapy, colon cleansers promise to “detox” the body and eliminate fatigue, weight gain, and headaches.  Using informercials and celebrities, they say they will “boost the immune system” and promote weight loss.

The problem is that there is not a shred of evidence that colon cleansing does any of these things.

And there is evidence that it can make holes in the colon requiring surgery, cause serious infections, lead to dehydration and heart and kidney damage, and sometimes kill.

Read the rest of this entry »

Dr. William I. Wolff

Dr. William Wolff died on August 20 at his home Manhattan.  He was 94.

In the mid 1960′s Dr. Wolff, working with his colleague Dr. Hiromi Shinya at Beth Israel Medical Center in New York, began studying how fiber optics and a long, soft, flexible tube might make it possible to see inside the entire length of the colon.  Together they developed  the first colonoscope.

In 1969, Dr. Shinya invented a wire snare and electrocautery making it possible for the team to remove polyps during a colonoscopy.

By 1973, Dr. Wolff and Dr. Shinya had performed over 2,000 colonoscopies in the Endoscopy Unit at Beth Israel, demonstrating that in skilled hands they could be done safely.  Their use of a wire loop snare and electrocautery made it possible to remove most polyps during the colonoscopy itself and avoid risky abdominal surgery.

Last year more than 1.6 million colonoscopies were done in the United States, preventing tens of thousands of future colon cancers.

Read the rest of this entry »

Join Fight Colorectal Cancer March 5 – 7, 2012 in Washington, DC

Registration is now open!

If you are diagnosed with stage III colon cancer, you will probably receive about six months of treatment with FOLFOX after surgery. Research shows that this treatment regimen helps prevent recurrence for some – but not all – patients with stage III colon cancer.  A clinical trial has been launched to answer two questions about this current standard of care:

1. Will recurrence rates go down if both FOLFOX and celecoxib (a non-steroidal anti-inflammatory drug similar to aspirin) are used for treatment?

2.  Will recurrence rates stay the same and long term side effects decrease if FOLFOX is used for three months?

Read the rest of this entry »

45,000 women were diagnosed with endometrial cancer in the United States in 2010 — and for nearly 900, cancer was due to Lynch syndrome.

Women who have Lynch syndrome have an increased risk of getting endometrial cancer during their lifetime that is as high as 60 percent. Often endometrial cancer (cancer of the lining of the uterus) is the first Lynch-related cancer diagnosed, earlier than colon or rectal cancer.

Identifying a mutation in these women can prevent future colorectal cancers and discover ovarian, gastric, and other Lynch cancers early when they can be treated successfully.

And not only does this help the woman with endometrial cancer, it helps her family as well if they are tested for the inherited mutation and take steps to reduce their risk of future cancers. Read the rest of this entry »